Next report date
Report period
Q1 2024
EPS estimate
−0.21USD
Revenue estimate
—
−234.63 MUSD
130.00 KUSD
118.13 M
Om Lyell Immunopharma, Inc.
Sektor
Bransch
VD
Lynn Seely
Webbplats
Huvudkvarter
South San Francisco
Employees (FY)
224
Grundat
2018
FIGI
BBG00RNXFN14
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
